PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Symptom | C0028754|obesity |
| Sentences | 15 |
| PubMedID- 22554352 | In previous studies that have considered obesity in patients with schizophrenia, weight or body mass index (bmi) was commonly used as measurement parameters. |
| PubMedID- 24346756 | The higher prevalence of obesity in patients with schizophrenia is a matter of clinical and public health concern; interventions to reduce weight to healthy levels would result in both improved health and quality of life among patients with schizophrenia. |
| PubMedID- 26016380 | Objective: to review recent advances in the epidemiology, pathobiology, and management of weight gain and obesity in patients with schizophrenia and to evaluate the extent to which they should influence guidelines for clinical practice. |
| PubMedID- 23570345 | In addition, obesity among patients with schizophrenia is associated with high medication costs, non-compliance with an antipsychotic medication regime. |
| PubMedID- 22997527 | The prevalence of obesity among patients with schizophrenia is increasing each year . |
| PubMedID- 22131945 | It also explains the common co-occurrence of schizophrenia with addiction, obesity and diabetes. |
| PubMedID- 24947974 | Background: obesity among patients with schizophrenia is a growing concern because being overweight is widely regarded as a major risk factor for cardiovascular disease and premature death. |
| PubMedID- 23805859 | In the northern finland 1966 birth cohort study, rates of obesity in patients with schizophrenia were 42% compared to 13% for rest of the cohort 9. |
| PubMedID- 24249923 | A number of explanations like lifestyle and dietary habits that facilitate the development of obesity among patients with schizophrenia, direct antipsychotic drug action on lipid and carbohydrate metabolism, certain alterations of the hypothalamic pituitary-adrenal axis (hpa) producing hypercortisolemia, and possible associated alterations in hippocampal volume9 have been proposed. |
| PubMedID- 22714874 | The prevalence of obesity among patients with schizophrenia was significantly greater than that in the healthy malaysian population, and affects the 3 main races in malaysia. |
| PubMedID- 22523667 | Antipsychotic medications have been considered the primary risk factor for obesity in schizophrenia, although the mechanisms by which they increase weight and produce metabolic disturbances are unclear. |
| PubMedID- 20079934 | obesity and smoking in patients with schizophrenia and normal controls: a case-control study. |
| PubMedID- 23691790 | Aim: many studies have reported a high prevalence of obesity in patients with schizophrenia compared to the general population. |
| PubMedID- 26064048 | Given the prevalence of obesity in patients with schizophrenia, it is important to consider the need for dose adjustments or special consideration in obese patients. |
| PubMedID- 25664341 | Prevention of weight gain and treatment of obesity among patients with schizophrenia taking atypical antipsychotics have become a priority in clinical practice and represent a major public health problem . |
Page: 1